title: Commentary: statins and fracture risk--unresolved questions.
authors.affiliation: Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Hebelstrasse 2, 4031 Basel, Switzerland. meierch@uhbs.ch
authors.forename: Christoph R
authors.initials: CR
authors.lastname: Meier
mesh_terms: D016022:Case-Control Studies; D004334:Drug Administration Schedule; D050723:Fractures, Bone / Q000517:prevention & control*; D006620:Hip Fractures / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D012107:Research Design; D018570:Risk Assessment / Q000379:methods
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors